Teater, Matthew R

Publications

Sort by

Co-Author Network

selected publications

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Stenberg cells reveals escape from NK cell recognition and an unfolded protein response. 2025 GET IT
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function. Cancer cell. 2024 Academic Article GET IT
Times cited: 26
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. 2024 GET IT
Times cited: 3
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment. Nature communications. 2024 Academic Article GET IT
Times cited: 17
ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer cell. 2024 Academic Article GET IT
Times cited: 26
SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer cell. 2024 Academic Article GET IT
Times cited: 24
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomas. 2023 GET IT
BTG1 mutation yields supercompetitive B cells primed for malignant transformation. Science (New York, N.Y.). 2023 Academic Article GET IT
Times cited: 27
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas. Cancer discovery. 2023 Editorial Article GET IT
Times cited: 13
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL. Cancer discovery. 2022 Academic Article GET IT
Times cited: 24
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis. Cancer discovery. 2022 Academic Article GET IT
Times cited: 22
Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival. Blood cancer discovery. 2021 Academic Article GET IT
Times cited: 20
Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL. Blood. 2021 Academic Article GET IT
Times cited: 30
Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence. Cancer discovery. 2021 Academic Article GET IT
Times cited: 180
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation. Nature immunology. 2021 Academic Article GET IT
Times cited: 28
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature. 2020 Academic Article GET IT
Times cited: 185
Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage. Molecular cell. 2020 Academic Article GET IT
Times cited: 28
Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes. Blood advances. 2020 Academic Article GET IT
Times cited: 39
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate. Cell. 2020 Academic Article GET IT
Times cited: 84
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. Nature cancer. 2020 Academic Article GET IT
Times cited: 52
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response. Cancer cell. 2020 Academic Article GET IT
Times cited: 117
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma. Cancer discovery. 2020 Academic Article GET IT
Times cited: 132
Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis. Cancer cell. 2019 Academic Article GET IT
Times cited: 97
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML. Cancer discovery. 2019 Academic Article GET IT
Times cited: 39
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition. Cancer discovery. 2019 Academic Article GET IT
Times cited: 250
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis. Cancer discovery. 2018 Academic Article GET IT
Times cited: 147
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth. The Journal of clinical investigation. 2018 Academic Article GET IT
Times cited: 48
AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis. Nature communications. 2018 Academic Article GET IT
Times cited: 61
EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop. Nature communications. 2017 Academic Article GET IT
Times cited: 146
Untangling the Web of Lymphoma Somatic Mutations. Cell. 2017 Comment GET IT
Times cited: 1
The new frontier of epigenetic heterogeneity in B-cell neoplasms. Current opinion in hematology. 2017 Review GET IT
Times cited: 10
Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma. Science translational medicine. 2017 Academic Article GET IT
Times cited: 52
CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas. Cancer discovery. 2016 Academic Article GET IT
Times cited: 227
Multi-tiered Reorganization of the Genome during B Cell Affinity Maturation Anchored by a Germinal Center-Specific Locus Control Region. Immunity. 2016 Academic Article GET IT
Times cited: 114
EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis. Cancer cell. 2016 Academic Article GET IT
Times cited: 201
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma. The Journal of clinical investigation. 2016 Academic Article GET IT
Times cited: 146
Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status". Nature medicine. 2016 Letter GET IT
Times cited: 7
Loss of BAP1 function leads to EZH2-dependent transformation. Nature medicine. 2015 Academic Article GET IT
Times cited: 310
DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID. Cell reports. 2015 Academic Article GET IT
Times cited: 92
The BCL6 RD2 domain governs commitment of activated B cells to form germinal centers. Cell reports. 2014 Academic Article GET IT
Times cited: 76
CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer. Cell reports. 2014 Academic Article GET IT
Times cited: 151
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer cell. 2013 Academic Article GET IT
Times cited: 719
Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cellular and molecular life sciences : CMLS. 2010 Academic Article GET IT
Times cited: 179
Quality control in microarray assessment of gene expression in human airway epithelium. BMC genomics. 2009 Academic Article GET IT
Times cited: 76
Trachea epithelium as a "canary" for cigarette smoking-induced biologic phenotype of the small airway epithelium. Clinical and translational science. 2009 Academic Article GET IT
Times cited: 14

more ...

less ...

Background

education and training

Ph.D., Weill Cornell Medical College, Cornell University 2017
M.S., New York University 2007
B.A., New York University 2004

Contact

full name

Matthew R Teater

primary email

mrt2001@med.cornell.edu

VIVO Weill Cornell Medical College

Matthew R Teater Instructor of Cancer Genomics in Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email